Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Clarity Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
Radiopharmaceutical emerges as the hottest space in biotech; here’s what it means for Clarity Pharma
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: Blinklab soars 32.5% in first healthcare IPO of 2024
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX gets another crack at record high, McGrath to be delisted after buyout
Health & Biotech
ASX Health Stocks: Clarity’s imaging agent can identify prostate cancer lesions at double the rate
Health & Biotech
ScoPo’s Powerplays: ASX healthcare 0.3% up as focus shifts to M&A activity in 2024
Health & Biotech
ASX Health Winners December: Health stocks beat market, look ‘undervalued’ going into 2024
Health & Biotech
ASX Health Stocks: Next Science jumps almost 10pc after XPERIENCE study published in science journal
Health & Biotech
Check Up: Introducing the Brain Atlas, the largest map of the human brain. And recent ASX biotech winners
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: Clarity Pharma says its drug could be effective in prostate cancer, shares jump 8pc
Health & Biotech
ASX Health Stocks: Clarity Pharma, Island Pharma set to embark on next steps of clinical trials
Health & Biotech
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?
Health & Biotech
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…
Health & Biotech
Check Up: Australian biotech sector continues to be a magnet for US investors
Health & Biotech
ASX Health Stocks: Althea says its cannabis beverage could generate $5m of sales in Canada
Health & Biotech